Elsevier

Metabolism

Volume 43, Issue 9, September 1994, Pages 1164-1170
Metabolism

Pregnancy in a patient with homozygous familial hypercholesterolemia treated with long-term low-density lipoprotein apheresis

https://doi.org/10.1016/0026-0495(94)90061-2Get rights and content

Abstract

The pregnancy and delivery of a subject with homozygous familial hypercholesterolemia (FH) and coronary artery disease (CAD) were monitored closely for signs of maternal and fetal distress. Biweekly treatment with low-density lipoprotein (LDL) apheresis using dextran-sulfate cellulose columns was continued throughout the pregnancy, and lipid and lipoprotein levels were evaluated. During the course of the pregnancy and delivery, no signs of maternal coronary insufficiency developed. Serial ultrasonographic measurements of fetal growth indices and the blood flow velocity waveforms (FVWs) of the uterine and umbilical artery did not reveal any sign of fetal growth retardation or insufficiency of the uteroplacental circulation, respectively. During pregnancy, time-averaged concentrations of serum total cholesterol (TC), LDL cholesterol (LDL-C), apolipoprotein (apo) B, and lipoprotein(a) [Lp(a)] showed a gradual decline. Notwithstanding LDL apheresis, a gradual twofold increase of serum triglyceride (TG) levels was found. In the second and third trimester, high-density lipoprotein cholesterol (HDL-C) levels showed a 55% increase that coincided with a 75% reduction in hepatic lipase activity in postheparin plasma, normalizing after parturition. After delivery, lp(a) levels showed an almost twofold increase, which could not be explained by the interruption of LDL apheresis alone, and may be caused by changes in gonadal steroids. Histologic examination of the placenta and the umbilical arteries revealed no atherosclerotic changes, infarctions, or lipid deposits. In general, long-term LDL apheresis in homozygous FH can delay the onset and complications of severe CAD. In case of a pregnancy, LDL apheresis seems feasible and should be continued during the pregnancy to prevent superimposed hyperlipidemia and placental insufficiency.

References (51)

  • MJTM Mol et al.

    Effects of synvinolin (MK-733) on plasma lipids in patients with familial hypercholesterolemia

    Lancet

    (1986)
  • RS Thompson et al.

    A comparison of Doppler ultrasound waveform indices in the umbilical artery. I. Indices derived from the maximum velocity waveform

    Ultrasound Med Biol

    (1986)
  • LGM Mulders et al.

    Uterine and umbilical artery blood flow velocity waveforms and their validity in the prediction of fetal comprise

    Eur J Obstet Gynaecol Reprod Biol

    (1989)
  • LGM Mulders et al.

    The uterine artery blood flow velocity waveform: Reproducibility and results in normal pregnancy

    Early Hum Dev

    (1988)
  • AFH Stalenhoef et al.

    Combined deficiency of apolipoprotein C-II and lipoprotein lipase in familial hyperchylomicronemia

    Metabolism

    (1981)
  • CS Apstein et al.

    Effect of intensive plasmapheresis on the plasma cholesterol concentration with familial hypercholesterolemia

    Atherosclerosis

    (1978)
  • A Yamamoto

    Regression of atherosclerosis in humans by lowering serum cholesterol

    Atherosclerosis

    (1991)
  • PT Kovanen et al.

    Increased binding of low density lipoprotein to liver membranes from rats treated with 17α-ethynyl estradiol

    J Biol Chem

    (1979)
  • M Shiomi et al.

    Increase in hepatic low-density lipoprotein receptor activity during pregnancy in Watanabe heritable hyperlipidemic rabbits: An animal model for familial hypercholesterolemia

    Biochim Biophys Acta

    (1987)
  • H Mabuchi et al.

    Normalisation of low-density lipoprotein levels and disappearance of xanthomas during pregnancy in a woman with heterozygous familial hypercholesterolemia

    Metabolism

    (1985)
  • R Zechner et al.

    Fluctuation of plasma lipoprotein-(a) concentrations during pregnancy and postpartum

    Metabolism

    (1986)
  • M Soma et al.

    Plasma Lp(a) concentration after oestrogen and progestagen in postmenopausal women

    Lancet

    (1991)
  • E Herrera et al.

    Role of lipoprotein lipase activity on lipoprotein metabolism and the fate of circulating triglycerides in pregnancy

    Am J Obstet Gynecol

    (1988)
  • T Kuusi et al.

    Postheparin plasma lipoprotein and hepatic lipase are determinants of hypo- and hyperalphalipoproteinemia

    J Lipid Res

    (1989)
  • MJ Tikkanen et al.

    Regulation of hepatic lipase and serum lipoproteins by sex steroids

    Am Heart J

    (1987)
  • Cited by (49)

    • A complicated pregnancy in homozygous familial hypercholesterolaemia treated with lipoprotein apheresis: A case report

      2019, Atherosclerosis Supplements
      Citation Excerpt :

      Hemodynamic stress developing during pregnancy can exacerbate pre-existing cardiovascular lesions and precipitate into acute maternal events [8]. Furthermore, atherosclerosis may affect utero-placental circulation and lead to placental insufficiency, intrauterine growth restriction and preterm birth [14,15]. Oxidative stress and reduced antioxidant defence enhance free radicals possible causing vascular endothelial damage leading to pregnancy complications such as pre-eclampsia [8].

    • Lipoprotein apheresis is essential for managing pregnancies in patients with homozygous familial hypercholesterolemia: Seven case series and discussion

      2016, Atherosclerosis
      Citation Excerpt :

      Managing these patents during child-bearing age presents many challenges for clinicians because LDL-C increases during gestation, statins and ezetimibe are contraindicated during pregnancy and lactation, and some patients may have aortic-valve disease and CAD. Therefore, LA is regarded as the most effective therapy to control LDL-C levels during pregnancy in patients with HoFH [4] [5] [6] [7]. However, only a few cases of pregnancy in HoFH patients have been reported and there is no guidance for overall management.

    • Severe dyslipidemia in pregnancy: The role of therapeutic apheresis

      2015, Transfusion and Apheresis Science
      Citation Excerpt :

      There are several evidence (case reports or case series) in which the authors describe the use of LDL apheresis successfully being performed in pregnant women largely with homozygous FH. This may be considered a therapeutic strategy in such individuals, especially those with elevated Lp(a) that has been shown to be effectively cleared by apheresis, when diet and drugs have failed [6,7,16,20,32–34]. In 2003 Klingel et al. [5] summarized experiences with 19 pregnancies of 16 patients with familial hyperlipoproteinemia, who became pregnant during chronic lipoprotein apheresis, or who were treated with lipoprotein apheresis because of acute disorders of lipid metabolism during pregnancy.

    • Pregnancy in homozygous familial hypercholesterolemia - Importance of LDL-apheresis

      2015, Atherosclerosis Supplements
      Citation Excerpt :

      The combination of HFH and pregnancy can be a fatal condition. In 1984, Kroon et al. reported that pregnancy in women with HFH is extremely rare and has a high mother and child mortality rate [10]. The prognosis of these patients has recently improved, however it still represents a serious medical problem with an estimated 30% possibility of acute coronary morbidity in mother or child [12].

    View all citing articles on Scopus
    View full text